|
Time-fold up- or down-expression of genes analyzed by real time PCR in SSc-MVECs versus N-MVECs |
||
| Gene name |
Time-fold up- or down-expression in SSc-MVECs relative to N-MVECs |
|
|
|
||
| KLK9 |
10.63 (8.26–13.67) |
↓ |
| KLK11 |
53.07 (41.44–67.98) |
↓ |
| KLK12 |
19.02 (11.61–31.17) |
↓ |
| PLXNB1 |
1.90 (1.41–2.13) |
↓ |
| DSG2 |
35.08 (28.23–43.73) |
↓ |
| IL8 |
2.85 (1.82–4.37) |
↑ |
| PLAU |
2.44 (1.48–3.65) |
↑ |
| PTX3 |
1.58 (1.29–1.87) |
↑ |
| CTGF |
1.42 (1.34–1.52) |
↑ |
|
Upward and downward arrows mean up-regulation and down-regulation in microvascular endothelial cells from patients with systemic sclerosis (SSc-MVECs), respectively. N-MVECs, microvascular endothelial cells from normal subjects. | ||
Giusti et al. Arthritis Research & Therapy 2006 8:R115 doi:10.1186/ar2002 |
||